RxDoctor Payments Data

Karri Berlin, APRN

Family · Ashland, KYNPI 1619521606

Payments from drug & device makers

$4,826in general payments, 2019–2025

Across 267 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$731
  • Regeneron Healthcare Solutions, Inc.$394
  • Johnson & Johnson$369
  • Takeda Pharmaceuticals U.S.A., Inc.$273
  • Ardelyx, Inc.$197
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$4,826100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,826 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$7,734
Medicare patients
106
Services billed
112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin20$58,190
LinzessLinaclotide30$22,376
Sucralfate15$4,436
Colestipol Hcl21$1,284
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates13$841
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg35$756
Dicyclomine Hcl25$623
Pantoprazole Sodium53$526
Omeprazole42$353
Ondansetron OdtOndansetron13$291
Famotidine29$281
Ondansetron Hcl13$110

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$731$58,19020 claims
AbbVieLinzess$1,305$22,37630 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,374 family providers in Kentucky.

Other family in Ashland

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →